Digitalna platforma ima za cilj da konkretne inovacije i tehnološka rešenja, proizvedena od strane akademske i istraživačke zajednice, učini dostupnim privatnim kompanijama. Ovo je usluga za automatsko preuzimanje, sinhronizaciju, sortiranje i prikazivanje informacija sa velikih naučnih platformi kao što su Academia.edu, Google Scholar ili Researchers Gate sa platforme EmpowerHR4Inno. Platforma se inicijalno fokusira na prioritetne sektore, prehrambenu industriju, zdravstveni turizam, horizontalni IT prioritet i nacionalno proizvedena rešenja sa tendencijom daljeg razvoja. Sljedeće informacije se mogu naći:
  • Biblioteka kurseva sa objavljenim podsadržajem VoS-a, rezultatima, drugim rešenjima i digitalnim alatima i HR modelima;
  • Skup funkcija koje omogućavaju slanje novijih, objavljenih članaka, radova korisnicima koji se registruju kao zainteresovani za određenu grupu vesti.
Walter de Gruyter GmbH
Risk factors for adverse drug reactions associated with clopidogrel therapy
Abstract This study aimed to investigate the possible influence of genetic and non-genetic factors on the incidence of clopidogrel adverse drug reactions (ADRs) in cardiology patients, including the most important CYP2C19 alleles, namely *2 and *17, as well as compliance, dose, drug interactions, and clinical factors. A total of 102 clopidogrel-treated adult Caucasian patients hospitalized at the Cardiology Department of the Clinical Center of Montenegro were enrolled in the study....
Preuzmite dokument 2022 Ivan Radosavljevic , Natasa Djordjevic , Majda Sahman , Snezana Mugosa , Zoran Todorovic
Walter de Gruyter GmbH
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
Abstract Clopidogrel is an antiplatelet drug that displays significant interindividual variability in treatment response. Its bioavailability depends on the function of P-glycoprotein (P-gp), which is coded by a highly polymorphic ABCB1 gene. Thus, the aim of this study was to investigate the effect of ABCB1 genetic polymorphism on clopidogrel efficacy and safety and to determine the frequency distribution of its most common single nucleotide polymorphisms (SNPs) in 106 Montenegrin...
Preuzmite dokument 2021 Natasa Djordjevic , Majda Sahman-Zaimovic , Snezana Mugosa , Zoran Todorovic , Jelena Cukic
National Library of Serbia
Adverse drug reactions associated with sunitinib therapy: Characteristics and risk factors
Background/Aim. Kidney tumors account for 2?3% of all tumors. Renal cell carcinoma (RCC) is the tenth most common malignancy. Sunitinib is used as the first treatment line in patients with a good and intermediate prognosis. The aim of this study was to analyze the risk factors, frequency, and adverse drug reactions (ADRs) of sunitinib in patients with metastatic RCC. Methods. The retrospective study included 170 patients treated at the Clinic for Oncology of the Clinical Center of Montenegro, Urology...
Preuzmite dokument 2021 Majda Sahman-Zaimovic , Nevenka Lukovac-Janjic , Zoran Dzamic , Snezana Mugosa
  • Previous
  • 1 (current)
  • Next
Partneri
Pretplatite se na repozitorijum